Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemente Ponzetti

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 21, 2009
FMEA: a model for reducing medical errorsMaria Laura Chiozza, Clemente Ponzetti
Clinicoeconomics and Outcomes Research : CEOR|June 11, 2016
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic surveyClemente Ponzetti, Monica Canciani, Massimo Farina, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 19, 2016
Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approachClemente Ponzetti, Monica Canciani, Massimo Farina, et al.
Neuroepidemiology|January 27, 2009
Community-based study of stroke incidence in the Valley of Aosta, Italy. CARe-cerebrovascular Aosta Registry: years 2004-2005Giovanni Corso, Edo Bottacchi, Guido Giardini, et al.
Journal of Nephrology|January 22, 2010
Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unitGiovanna Bonfant, Pietro Belfanti, Giuseppe Paternoster, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 21, 2009
FMEA: a model for reducing medical errorsMaria Laura Chiozza, Clemente Ponzetti
Clinicoeconomics and Outcomes Research : CEOR|June 11, 2016
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic surveyClemente Ponzetti, Monica Canciani, Massimo Farina, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 19, 2016
Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approachClemente Ponzetti, Monica Canciani, Massimo Farina, et al.
Neuroepidemiology|January 27, 2009
Community-based study of stroke incidence in the Valley of Aosta, Italy. CARe-cerebrovascular Aosta Registry: years 2004-2005Giovanni Corso, Edo Bottacchi, Guido Giardini, et al.
Journal of Nephrology|January 22, 2010
Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unitGiovanna Bonfant, Pietro Belfanti, Giuseppe Paternoster, et al.
Pageof 1